GlaxoSmithKline (GSK) Consumer Healthcare announced that it has reached an agreement with Laclede, a privately held company, to purchase the leading Dry Mouth brand Biotene for $170 million. The transaction is subject to regulatory review by competition authorities in the United States and Europe, and is expected to complete by early 2009.
The details can be read here.
No comments:
Post a Comment